Piper Jaffray Starts AcelRx Pharmaceuticals (ACRX) at Overweight
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 42
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 42
Join SI Premium – FREE
Piper Jaffray initiates coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with an Overweight. PT $7.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- BofA Securities Reinstates Rentokil Initial Plc. (RTO:LN) (RTOKY) at Buy
- Ladenburg Thalmann Starts Turn Therapeutics (TTRX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
